Quantbot Technologies’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$136K Buy
+253
New +$130K 0.01% 1390
2024
Q2
Sell
-100
Closed -$26.7K 1722
2024
Q1
$26.7K Buy
+100
New +$23.6K ﹤0.01% 1392
2023
Q4
Sell
-496
Closed -$72.4K 1824
2023
Q3
$72.4K Buy
+496
New +$93.4K ﹤0.01% 1173
2023
Q1
Sell
-700
Closed -$203K 1851
2022
Q4
$203K Buy
+700
New +$68.5K 0.01% 894
2021
Q3
Sell
-238
Closed -$23K 1735
2021
Q2
$23K Buy
+238
New +$28.2K ﹤0.01% 1204
2021
Q1
Sell
-95
Closed -$10K 1629
2020
Q4
$10K Buy
+95
New +$11.6K ﹤0.01% 1103
2020
Q2
Sell
-295
Closed -$19K 1310
2020
Q1
$19K Buy
+295
New +$24.6K 0.01% 598
2019
Q4
Sell
-1,400
Closed -$120K 1451
2019
Q3
$120K Buy
1,400
+1,100
+367% +$103K 0.01% 798
2019
Q2
$31K Buy
+300
New +$32.1K ﹤0.01% 976
2018
Q2
Sell
-541
Closed -$63K 1378
2018
Q1
$63K Sell
541
-771
-59% -$95.2K 0.01% 946
2017
Q4
$120K Buy
+1,312
New +$74.9K 0.01% 805

Other funds holding MDGL

Quantbot Technologies's MDGL Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 253 shares worth $136K. The stake represents 0.01% of the portfolio and ranks #1390 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in MDGL as recently as Q1 2024.

Quantbot Technologies first reported a position in MDGL in Q4 2017 and has held it in 11 quarters since. The position peaked at $203K in Q4 2022. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Quantbot Technologies held 253 shares of Madrigal Pharmaceuticals worth $136K as of Q2 2026.
  • Madrigal Pharmaceuticals was a new Quantbot Technologies position in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1390 holding.
  • Quantbot Technologies first reported a position in Madrigal Pharmaceuticals in Q4 2017 and has held it in 11 quarters since.
  • Quantbot Technologies's Madrigal Pharmaceuticals position peaked at $203K in Q4 2022.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.